American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults.
Saved in:
| Title: | American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults. |
|---|---|
| Authors: | O'Dwyer K; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Winestone LE; Division of Allergy, Immunology, and Blood & Marrow Transplant, University of California, San Francisco Benioff Children's Hospitals, San Francisco, CA., Cheung MC; Division of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Benitez L; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI., Buldini B; Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padua University, Padua, Italy.; Pediatric Onco-Hematology, Stem Cell Transplant and Gene Therapy Laboratory, Istituto di Ricerca Pediatrica, Città della Speranza, Padua, Italy., Cole PD; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ., Damlaj M; Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates., Dholaria B; Vanderbilt University Medical Center, Nashville, TN., Dias AL; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Dils A; Department of Internal Medicine, University of Michigan Medicine, Ann Arbor, MI., Fritsch M; Texas Children's Cancer and Hematology Center, Houston, TX., Greer J; Vanderbilt University Medical Center, Nashville, TN., Hayes-Lattin B; Oregon Health and Science University Knight Cancer Institute, Portland, OR., Henry M; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI., Jaffe A; Halethorpe, MD., Jamy O; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL., Kebriaei P; The University of Texas MD Anderson Cancer Center, Houston, TX., Mehrtens I; Biological Sciences Division, Department of Psychiatry and Behavioral Neuroscience, Section of Child and Adolescent Psychiatry, University of Chicago Medicine, Chicago, IL., Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Wilde L; Division of Hematologic Malignancies, Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia, PA., Young PA; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA., Mai HJ; Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, RI., Kanaan G; Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, RI., Sereda Y; Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, RI., Saldanha IJ; Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD., Balk EM; Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, RI., Gupta S; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada. |
| Source: | Blood advances [Blood Adv] 2026 Jul 14; Vol. 10 (13), pp. 4726-4756. |
| Publication Type: | Journal Article; Practice Guideline |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
